1
|
Nakama Y, Shimamatsu K, Morita T, Kawano R, Sakata K, Sueyoshi S, Murakami N, Yomoda T, Sasaki S, Taniwaki S, Taniguchi H, Yoshinaga Y, Mikasa K, Takagi K, Yoshida A. [A Case of Solitary Liver Metastasis of Low-Grade Endometrial Stromal Sarcoma 31 Years after Resection of Primary Lesion]. Gan To Kagaku Ryoho 2022; 49:1777-1779. [PMID: 36732996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
A 73-year-old woman was referred to our hospital after a liver tumor was discovered during an abdominal ultrasonography. Thirty-one years ago, she underwent a total hysterectomy for uterine myoma and was diagnosed with a leiomyoma. Twenty years ago, she underwent a bilateral oophorectomy for an ovarian tumor and was diagnosed with a luteinized theca cell tumor accompanied by sclerosing peritonitis. A CT scan and MRI revealed a 65-mm tumor in the S6-7 of the liver. There was no sign of any lesions other than in the liver, and TACE was performed for suspected hepatocellular carcinoma. However, a favorable treatment outcome was unable to be obtained and a posthepatic segmental resection was performed. Histopathological morphology suggested a similarity to endometrial stromal cells and, considering the history of myoma of the uterus and ovarian tumor, immunohistological staining was carried out. The myoma of the uterus and the ovarian and liver tumors were all CD10(+), α⊖SMA(-), MIB-1 index 3%. The uterine myoma, which was initially operated on, was rediagnosed as a low-grade endometrial stromal sarcoma. After 11 years, ovarian metastasis was observed, and after 31 years liver metastasis occurred. Examples of resection of liver metastasis of endometrial stromal sarcoma are extremely rare and, we will include a review of the literature in this report.
Collapse
|
2
|
Tomoeda H, Mikasa K, Chihara S, Sawada K, Tanaka H. Prediction of Postoperative Cerebral Infarction after Cardiovascular Surgery Using Quantitative Measurement of Cerebral Blood Flow with Brain Single-Photon Emission Computed Tomography. Ann Vasc Dis 2018; 11:511-519. [PMID: 30637007 PMCID: PMC6326055 DOI: 10.3400/avd.oa.18-00116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Prediction of postoperative cerebral infarction after cardiovascular surgery is difficult. The present study investigated whether quantitative evaluation of preoperative cerebral blood flow used in the Japanese EC-IC Bypass Trial (JET) study is useful for the prediction of postoperative cerebral infarction after cardiovascular surgery. First, patients were divided into two groups based on preoperative cerebral blood flow. In an evaluation using preoperative imaging, patients with good or mildly decreased preoperative cerebral blood flow, divided into clinical stage I or II by quantitative evaluation showed no postoperative cerebral infarction. However, 24% of patients with poor cerebral blood flow who were categorized as clinical stage II, experienced postoperative cerebral infarction. The incidence rate was not statistically significantly different when the groups were compared. Second, patients were divided into two groups based on the anatomical area of the brain affected corresponding to clinical stage II. Patients with a 10% and greater brain involvement had a significantly higher incidence of postoperative cerebral infarction (38%) compared to others (0%, p<0.01). This method may be useful for the prediction of postoperative cerebral infarction after cardiovascular surgery, but a further prospective study is needed. (This is a translation of J Jpn Coll Angiol 2017; 57: 125–133.)
Collapse
Affiliation(s)
- Hiroshi Tomoeda
- Department of Cardiovascular Surgery, Chikugo City Hospital, Chikugo, Fukuoka, Japan
| | - Keita Mikasa
- Department of Surgery, Iizuka City Hospital, Iizuka, Fukuoka, Japan
| | - Shingo Chihara
- Department of Cardiovascular Surgery, Yokokura Hospital, Miyama, Fukuoka, Japan
| | - Kentaro Sawada
- Department of Surgery, Saiseikai Futsukaichi Hospital, Chikushino, Fukuoka, Japan
| | - Hiroyuki Tanaka
- Department of Cardiovascular Surgery, Kurume University School of Medicine, Kurume, Fukuoka, Japan
| |
Collapse
|
3
|
Furuyama T, Onohara T, Mikasa K, Kishimoto J, Yamashita M, Okamoto M, Yamamoto T, Shimoe Y, Okada M, Takahashi T, Ishibashi Y, Nakai M, Suhara H, Kasashima F, Endo M, Nishina T, Kei J, Mizuno A, Handa N. Is Endovascular Aneurysm Repair a Relative Contraindication for Patients with Preoperative Renal Dysfunction? Ann Vasc Dis 2015; 8:187-91. [PMID: 26421065 DOI: 10.3400/avd.oa.15-00072] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Accepted: 07/16/2015] [Indexed: 12/31/2022] Open
Abstract
UNLABELLED Whether endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) is a relative contraindication in patients with preoperative renal dysfunction (Pre-RD), remains controversial because the contrast medium may induce nephrotoxicity. In this study 1658 patients were treated at ten Japanese medical centers between January 2005 and March 2011 (Open surgery (OS) vs. EVAR: n = 1270 vs. n = 388). They were retrospectively analyzed. Multiple logistic regression analysis (MLRA) with pre- and intra-operative variables was applied to all patients. The endpoints induced onset of new dialysis and postoperative renal dysfunction (Post-RD), were defined as a 50% decrease or more from the preoperative estimated glomerular filtration rate (eGFR) level. RESULTS Early mortality, Post-RD, incidence of new dialysis in all patients were 1.6% (OS: EVAR = 1.9%:0.8%), 6% (OS: EVAR = 8%:2.3%) and 1.4% (OS: EVAR = 1.5%:1.0%) respectively. MLRA identified operation time, clamp of renal artery as risk factors for Post-RD, and operation time and Pre-eGFR level as risk factors for new dialysis. CONCLUSION Although Post-RD was more frequently observed in the OS group, MLRA showed that the choice of OS or EVAR was not a risk factor for Post-RD and new dialysis. It was strongly suggested that using contrast medium during EVAR is not a contraindication to AAA repair in patients with Pre-RD. (This article is a translation of J Jpn Coll Angiol 2014; 54: 13-18.).
Collapse
Affiliation(s)
- Tadashi Furuyama
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Toshihiro Onohara
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Keita Mikasa
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Jyunji Kishimoto
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Masafumi Yamashita
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Minoru Okamoto
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Tsuyoshi Yamamoto
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Yasushi Shimoe
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Masahiro Okada
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Toshiki Takahashi
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Yoshimitsu Ishibashi
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Mikizou Nakai
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Hitoshi Suhara
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Fuminari Kasashima
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Masamitsu Endo
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Takeshi Nishina
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Jyunichi Kei
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Akihiro Mizuno
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| | - Nobuhiro Handa
- National Hospital Organization Network Study Group in Japan for Abdominal Aortic Aneurysm
| |
Collapse
|
4
|
Handa N, Onohara T, Okamoto M, Yamamoto T, Shimoe Y, Okada M, Ishibashi Y, Yamashita M, Takahashi T, Kasashima F, Kishimoto J, Mizuno A, Kei J, Nakai M, Suhara H, Endo M, Nishina T, Furuyama T, Kawasaki M, Mikasa K, Ueno Y. Early outcomes of open abdominal repair versus endovascular repair for abdominal aortic aneurysm: report from national hospital organization network study in Japan. Ann Vasc Dis 2013; 5:172-9. [PMID: 23555507 DOI: 10.3400/avd.oa.12.00010] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2012] [Accepted: 02/23/2012] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE Early outcomes of open abdominal repair (OS) versus endovascular repair (EVAR) for abdominal aortic aneurysm were retrospectively analyzed, after commercialized devices for EVAR had become available in Japan. PATIENTS AND METHODS A total of 781 consecutive patients (OS, n = 522; EVAR, n = 259) were treated at ten medical centers between January 2008 and September 2010. The OS group comprised patients with preoperative shock (SOS, n = 34) and without shock (NOS, n = 488). RESULTS Patients in the EVAR group were 3 years older than those in the NOS group. There was greater prevalence of hostile abdomen, on dialysis, chronic obstructive pulmonary disease on inhaled drug, and cerebrovascular disease in the EVAR group than in the NOS group. Surgical mortality was 16 cases (2.0% in all patients, EVAR: 0.8%, NOS: 1.4%, SOS: 21%). Hospital stay >30 days was documented in 52 (11%) with NOS, 11 (33%) with SOS, and 8 (3%) with EVAR. Thirty late deaths included 6 aneurysm related death and 14 cardiovascular causes at a mean follow up of 1.0 year. The survival rates freedom from all cause death at one year, were 95 ± 1% in NOS and 94 ± 2% in EVAR respectively. CONCLUSION Though significant differences in patient characteristics among three groups were noted, early results were satisfactory.
Collapse
Affiliation(s)
- Nobuhiro Handa
- Author Affiliations and National Hospital Organization Network Study Group for Abdominal Aortic Aneurysm in Japan are listed at the end of the article
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Fukunaga S, Ueda T, Mori R, Shintani Y, Nata S, Mikasa K, Kanaya K, Akashi H, Aoyagi S. [Long-term results of aortic root replacement with a composite graft]. Kyobu Geka 2009; 62:947-951. [PMID: 19827546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
We analyzed the long-term results of aortic root replacement with a composite graft. Since 1992, 127 patients had undergone aortic root replacement with a composite graft. There were 92 men and 35 women with a mean age of 56.5 years. There were 69 patients with annuloaortic ectasia, 17 aortic dissections, and 41 ascending aortic dilatation due to aortic valve disease. Marfan syndrome was diagnosed in 19 patients. As surgical procedure, button technique was used in 90 patients, Cabrol technique in 11, and Piehler technique in 26. Open distal anastomosis was performed in 82 patients to avoid clamp injury of rest aorta. Early mortality was 3.1% and no major morbid events had occurred. Follow-up was completed in 95.9% of the patients and the mean follow-up period was 6.1 years. Actuarial survival at 5, 10, and 15 years was 86.2%, 83.4%, and 83.4%, respectively. Actuarial freedom from aortic valve reoperation at 10 and 15 years was 99.2% and 95.7%, respectively. The results of aortic root replacement with a composite graft were excellent. This procedure should be the 1st choice for surgical treatment of the aortic root disease.
Collapse
Affiliation(s)
- Shuji Fukunaga
- Department of Surgery, Kurume University School of Medicine, Kurume, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Ishihara K, Hiromatsu S, Shintani Y, Kanaya K, Mikasa K, Aoyagi S. Clinical outcome of perioperative nonpermanent vena cava filter placement in patients with deep venous thrombosis or blood stasis of the vein. Surg Today 2009; 39:764-9. [PMID: 19779772 DOI: 10.1007/s00595-009-3959-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2008] [Accepted: 02/10/2009] [Indexed: 11/30/2022]
Abstract
PURPOSE To evaluate the recent clinical experience with nonpermanent inferior vena cava (IVC) filter placement preoperatively, especially with regard to patients who had deep venous thrombosis (DVT) due to compression by a tumor or an aneurysm. METHODS Preoperative prophylactic IVC filter placement was performed between October 2002 and March 2008 in 48 of 83 patients who underwent IVC filter placement. IVC filter placement was performed preoperatively in 35 of the 48 patients due to DVT located distally in an iliac vein or due to IVC compression by a tumor or aneurysm. This study examined the early and mid-term outcomes resulting from nonpermanent IVC filter placement. RESULTS The mean implantation period was 11.1 +/- 9.3 days (range, 3-56 days). Three patients (8.6%) experienced minor complications during the IVC filter placement. A thrombus was captured in the filter in 4 patients (8.8%). One patient in whom the filter was left as a permanent filter died during the follow-up period. No patient experienced any pulmonary embolus during the follow-up period. CONCLUSION Nonpermanent IVC filter insertion is perioperatively useful in surgical procedures that eliminate the compression of the vein by an excision of either the tumor or aneurysm compressing the vein.
Collapse
Affiliation(s)
- Kenji Ishihara
- Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
| | | | | | | | | | | |
Collapse
|
7
|
Sakamoto M, Mikasa K, Majima T, Hamada K, Konishi M, Maeda K, Kita E, Narita N. Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer. Chemotherapy 2001; 47:444-51. [PMID: 11786660 DOI: 10.1159/000048556] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
We have previously reported that long-term treatment with clarithromycin (CAM) increased the median survival of patients with non-small cell lung cancer, and improved various clinical parameters in these patients. In the present study, CAM was administered to 33 patients with unresectable primary non-small cell lung cancer, who had received chemotherapy, radiotherapy or both (basic cancer therapy). Patients with clinical backgrounds matched to the CAM group, who did not receive CAM treatment, were included into this study as a control group (non-CAM group). CAM treatment was initiated 4 weeks after the basic cancer therapy. The non-CAM group did not receive a placebo. Before and after the 3-month treatment with CAM, body weight, serum levels of interleukin-6 (IL-6, a cytokine which, together with TNF-alpha, plays a crucial role in the development of cancer cachexia), total protein, albumin, cholinesterase and hemoglobin were measured for the evaluation of the patients' clinical status. There were no statistically significant differences in serum levels of IL-6 between the CAM group before the treatment and the non-CAM group. After 3 months of CAM treatment, serum levels of IL-6 significantly decreased. In contrast, body weight, cholinesterase, and hemoglobin increased to a significant extent. Among these four parameters, however, the decrease in serum IL-6 levels was only statistically correlated with the increase in body weight, but not with that in other parameters. Furthermore, CAM-treated patients whose serum IL-6 levels were decreased after 3 months of treatment survived longer: there was a statistically significant correlation between the decrease in serum IL-6 and survival time. In contrast, in the non-CAM group, these parameters did not change significantly during the study. These results suggest that CAM may reduce the progression of cancer-associated cachexia.
Collapse
Affiliation(s)
- M Sakamoto
- Department of Internal Medicine II, Nara Medical University, 840 Shijyou-cho, Kashihara, Nara 634-8522, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Maeda K, Mikasa K. [Anti-microbial sensitivities of bacteria isolated from patients with chronic lower respiratory tract infection under long-term macrolide therapy]. Jpn J Antibiot 2001; 54 Suppl C:106-8. [PMID: 12575432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
|
9
|
Konishi M, Takahashi K, Majima T, Kasahara K, Yoshimoto E, Murakawa K, Sakamoto M, Maeda K, Mikasa K, Sano R, Masutani T, Narita N. [Pathogenetic study on bronchopulmonary infections in 1,416 patients by transtracheal aspiration method]. Kansenshogaku Zasshi 2001; 75:961-9. [PMID: 11766379 DOI: 10.11150/kansenshogakuzasshi1970.75.961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We have performed transtracheal aspiration (TTA) in 1,416 patients, who were suspected to have bronchopulmonary infection, in order to collect non-contaminated specimens directly from the lower airway. The overall isolation rates in 1,416 TTA were 68.7% for any microorganisms. Aerobes had a high incidence but many kinds of microorganisms were associated with bronchopulmonary infections. Haemophilus influenzae was the major pathogen in patients with acute bronchitis. Streptococcus pneumoniae was the most important pathogen and mycoplasma was often isolated in patients with community-acquired pneumonia. Major pathogens of nosocomial pneumonia consisted of alpha-streptococcus spp., anaerobes and Pseudomonas aeruginosa. Anaerobes were isolated from transtracheal aspirates in 20 of 33 episodes of lung abscesses. H. influenzae and P. aeruginosa were the main persistent pathogens and H. influenzae, S. pneumoniae and anaerobes were important exacerbated pathogens in patients with chronic lower respiratory tract infection. S. pneumoniae was isolated more from TTA than expectorated sputa. Oropharyngeal flora bacteria were easily isolated in the culture of expectorated sputa. We assessed the final diagnosis or causative factor in 443 patients whom no microorganism was isolated from transtracheal aspirates. The final diagnosis was infectious diseases in 52 patients (11.7%) and non-infectious diseases in 80 patients (18.1%), respectively. The causative factor was unsuited TTA sample in 81 patients (18.3%), preceding antimicrobial chemotherapy in 95 patients (21.4%) and unknown in 135 patients (30.5%), respectively. The pathogenesis of bronchopulmonary infections is complex and various microorganisms are associated with pathogens of bronchopulmonary infections. Therefore, we should accurately diagnose the pathogens in patients with bronchopulmonary infections. TTA is one of the useful methods that we can accurately detect the respiratory pathogens.
Collapse
Affiliation(s)
- M Konishi
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Maeda K, Mikasa K, Konishi M, Takahashi K, Majima T, Murakawa K, Yoshimoto E, Sakamoto M, Narita N, Sano R, Masutani T, Nakamura S. [Acute exacerbations due to Streptococcus pneumoniae in chronic lower respiratory tract infections during long-term macrolide therapy]. Kansenshogaku Zasshi 2001; 75:846-50. [PMID: 11712358 DOI: 10.11150/kansenshogakuzasshi1970.75.846] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In Japan, long-term 14-membered macrolide administration is chosen as a first line therapy against chronic lower respiratory tract infections (CLRTIs) such as diffuse panbronchiolitis, bronchiectasis and chronic bronchitis. However, sometimes acute exacerbations occur in these cases, even if therapy is effective. We investigated 18 episodes of CLRTIs exacerbations that were caused by Streptococcus pneumoniae during long-term macrolides therapy from 1991 to 1999 to clarify the clinical features and prevalence of antimicrobial resistance in S. pneumoniae. Exacerbations did not occur only in winter season, but also in other seasons. Among 18 episodes of exacerbation, only 7 episodes (39%) revealed infiltration in chest roentogenogram and few episodes revealed marked elevations of inflammation markers in laboratory data. Intermediate resistance or resistance rates of S. pneumoniae isolated from sputum or transtracheal aspiration were 100% to erythromycin, 67% to clindamycin or minocycline, 11% to ampicillin, and 0% to cephazoline or imipenem. Coresistance to erythromycin, clindamycin and minocycline was seen in a half of the episodes. Resistance was not correlated with the duration of macrolides administration. All episodes were mainly treated with beta-lactam agents or fluoroquinolones and cured successfully. These findings suggest that acute exacerbations in CLRTIs caused by S. pneumoniae during long-term macrolides therapy do not reveal severe clinical aspects and can be treated successfully at present, but attention should be paid to the trend of antibiotic susceptibility in S. pneumoniae.
Collapse
Affiliation(s)
- K Maeda
- Department of General Medicine and Clinical Investigation, Nara Medical University, Nara, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Murakawa Y, Tsutsumi M, Murata N, Sasaki Y, Tsujiuchi T, Mikasa K, Narita N, Konishi Y. [Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats]. Jpn J Antibiot 2001; 54 Suppl A:53-8. [PMID: 11439906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
|
12
|
Sakamoto M, Mikasa K, Majima T, Hamada K, Konishi M, Yoshimoto E, Takahashi S, Narita N, Maeda K, Murakawa K, Kita E. [Suppression of non-small-cell lung carcinoma metastasis with clarithromycin]. Jpn J Antibiot 2001; 54 Suppl A:40-3. [PMID: 11439903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
|
13
|
Sakamoto M, Mikasa K, Majima T, Hamada K, Konishi M, Maeda K, Murakawa K, Yoshimoto E, Takahashi K, Narita N, Kita E. The effect of clarithromycin treatment on natural killer cell activity in patients with advanced non-small cell lung cancer. Lung Cancer 2000. [DOI: 10.1016/s0169-5002(00)80944-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
14
|
Mikasa K. [Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment]. Jpn J Antibiot 2000; 53:253-60. [PMID: 10868303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
|
15
|
Kita E, Yunou Y, Kurioka T, Harada H, Yoshikawa S, Mikasa K, Higashi N. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 2000; 68:1207-14. [PMID: 10678928 PMCID: PMC97269 DOI: 10.1128/iai.68.3.1207-1214.2000] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In a previous study, we showed that infection with Shiga toxin (Stx)-producing Escherichia coli O157:H7 (strain Sm(r)N-9) caused neurologic symptoms in malnourished mice with positive immunoreactions of Stx2 in brain tissues. The present study explores the mechanism of how Stx injures the vascular endothelium to enter the central nervous system in mice. Oral infection with strain Sm(r)N-9 elicited a tumor necrosis factor alpha (TNF-alpha) response in the blood as early as 2 days after infection, while Stx was first detected at 3 days postinfection. In the brain, TNF-alpha was detected at day 3, and its quantity was increased over the next 3 days. Frozen sections of the brains from moribound mice contained high numbers of apoptotic cells. Glycolipids recognized by an anti-Gb3 monoclonal antibody were extracted from the brain, and purified Stx2 was able to bind to the glycolipids. In human umbilical vascular endothelial cells (HUVEC) cultured with fluorescein-labeled Stx2 (100 ng/ml), TNF-alpha (20 U/ml) significantly facilitated the intracellular compartmentalization of fluorescence during 24 h of incubation, suggesting the enhanced intracellular processing of Stx2. Consequently, higher levels of apoptosis in HUVEC were found at 48 h. Short-term exposure of HUVEC to Stx2 abrogated their apoptotic response to subsequent incubation with TNF-alpha alone or TNF-alpha and Stx2. In contrast, primary exposure of HUVEC to TNF-alpha followed by exposure to Stx2 alone or TNF-alpha and Stx2 induced apoptosis at the same level as obtained after 48-h incubation with these two agents. These results suggest that the rapid production of circulating TNF-alpha after infection induces a state of competence in vascular endothelial cells to undergo apoptosis, which would be finally achieved by subsequent elevation of Stx in the blood. In this synergistic action, target cells must be first exposed to TNF-alpha. Such cell injury may be a prerequisite to brain damage after infection with Stx-producing E. coli O157:H7.
Collapse
Affiliation(s)
- E Kita
- Department of Bacteriology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
| | | | | | | | | | | | | |
Collapse
|
16
|
Kuge T, Sakamoto M, Nomiyama H, Koyama N, Mikasa K, Narita N. [Lambert-Eaton myasthenic syndrome in a patient with small cell lung cancer]. Nihon Naika Gakkai Zasshi 2000; 89:350-2. [PMID: 10756651 DOI: 10.2169/naika.89.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- T Kuge
- Department of Internal Medicine II, Nara Medical University, Kashihara
| | | | | | | | | | | |
Collapse
|
17
|
Sakamoto M, Mikasa K, Majima T, Konishi M, Maeda K, Yoshimoto E, Murakawa K, Takahashi K, Kita E, Narita N. [Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period]. Jpn J Antibiot 2000; 53 Suppl A:56-9. [PMID: 10756453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
|
18
|
Abstract
Clarithromycin (CAM) increased the median survival of patients with unresectable non-small-cell lung cancer who had received chemotherapy and/or radiotherapy [Chemotherapy 1997;43:288-296]. The present study was performed to ascertain whether CAM alone exhibits an antitumor effect against Lewis lung carcinoma (LLC) and to analyze the nature of its adjuvant effect on LLC-inoculated C57BL/6 mice. CAM at 10 mg/kg/day retarded the growth of subcutaneously inoculated LLC cells; consequently, the mean survival time of mice with LLC increased. This treatment was also effective in reducing the number of tumor nodules in the lung after intravenous inoculation with LLC cells. When tumor-bearing mice received an intravenous injection of vindesine sulfate (7 mg/kg) and cisplatin (6 mg/kg) 7 days after tumor inoculation, the chemotherapeutic effect was significantly enhanced by CAM treatment when it started 7 days after chemotherapy, but not when it started the day after chemotherapy. The delayed initiation of CAM treatment resulted in the enhancement of natural killer cell activity and CD8+ T cell cytotoxicity and increased the number of interferon-gamma-producing T cells and interleukin-4-producing T cells. These findings indicate that CAM can exhibit an antitumor effect by itself and also induce the well-balanced expansion of helper T cell subsets in tumor-bearing mice recovering from the immunosuppression caused by chemotherapy. CAM may therefore be a promising adjuvant drug in anticancer chemotherapy, and treatment with this macrolide should be initiated at some interval after basic cancer therapy.
Collapse
Affiliation(s)
- K Hamada
- Department of Medicine II, Nara Medical University, Kashihara, Nara, Japan
| | | | | | | | | | | | | |
Collapse
|
19
|
Majima T, Mikasa K, Sakamoto M, Hamada K, Konishi M, Maeda K, Yoshimoto E, Murakawa K, Takahashi K, Kita E, Narita N. [Administration of clarithromycin (CAM) to non-small cell lung cancer]. Jpn J Antibiot 2000; 53 Suppl A:52-5. [PMID: 10756452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
|
20
|
Yoshimoto E, Konishi M, Takahashi K, Majima T, Ueda K, Murakawa K, Sakamoto M, Maeda K, Mikasa K, Narita N, Sano R, Masutani T, Ishii Y, Yamaguchi K. [Enterococcus gallinarum septicemia in a patient with acute myeloid leukemia]. Kansenshogaku Zasshi 1999; 73:1078-81. [PMID: 10565126 DOI: 10.11150/kansenshogakuzasshi1970.73.1078] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
A 62-year-old male was admitted with complaints of fever and body weight loss. The patient was diagnosed as acute myeloid leukemia (M1) and chemotherapy was started. About 80 days after admission, the patient developed diarrhea with high fever. And E. gallinarum was isolated from the blood culture. We carried out PCR using primers for vanA, vanB and vanC in our E. gallinarum, and showed the existence of the vanC1. This organism should be considered as one of the possible pathogenes in the infectious complications of the immuno-compromized patient.
Collapse
Affiliation(s)
- E Yoshimoto
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Maeda K, Teranishi T, Majima T, Ueda K, Yoshimoto E, Sakamoto M, Konishi M, Hamada K, Mikasa K, Narita N. [A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. Nihon Kokyuki Gakkai Zasshi 1999; 37:699-703. [PMID: 10540836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
A 32-year-old woman with common variable immunodeficiency (CVID) accompanied by sinopulmonary infection was evaluated for purulent sputum, cough, and nasal obstruction that did not respond to regular intravenous immunoglobin (IVIG) infusion. Chest X-ray films revealed bronchiectasis affecting both lung bases, and a bacteriological examination of sputum was positive for Pseudomonas aeruginosa. Long-term chemotherapy with erythromycin (EM) was started, and the patient's respiratory symptoms gradually subsided. Sinopulmonary infection is the dominant clinical complication in patients with CVID. This case suggested that long-term EM chemotherapy is useful for the treatment of IVIG-refractory sinopulmonary infection associated with CVID.
Collapse
Affiliation(s)
- K Maeda
- Department of Internal Medicine II, Nara Medical University, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Mikasa K, Furunishi M, Maeda K, Sakamoto M, Ueta K, Mashima T, Kita E, Narita N. [Clinical application of the new action of macrolide preparations to respiratory diseases]. Nihon Naika Gakkai Zasshi 1999; 88:1533-40. [PMID: 10475020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
|
23
|
Konishi M, Mori K, Yoshimoto E, Takahashi K, Majima T, Ueda K, Murakawa K, Sakamoto M, Maeda K, Mikasa K, Narita N, Sano R, Masutani T. [Clinical evaluation of anaerobic infections in patients with bronchopulmonary infections diagnosed by transtracheal aspiration]. Kansenshogaku Zasshi 1999; 73:675-80. [PMID: 10481403 DOI: 10.11150/kansenshogakuzasshi1970.73.675] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We evaluated the clinical and bacteriologic features in the patients with bronchopulmonary infections isolated anaerobes from transtracheal aspirates between April 1990 and March 1998. Some anaerobe was isolated in 42 (10.9%) in 387 patients whom we performed transtracheal aspiration (TTA), in 42 (15.7%) of 268 in whom some organism was isolated from TTA, or in 42 (16.3%) of 257 patients in whom some bacterium excluding acid-fast bacteria, fungi or mycoplasma from TTA. The isolation rate of anaerobic bacteria was 93.3% in the patients with lung abscess, 22.7% in the patients with nosocomial pneumonia, 19.4% in the patients with community-acquired pneumonia, 26.7% in the patients with acute exacerbation of chronic lower respiratory tract infection (CLRTI), 1.6% in the patients with persistent infection of CLRTI, and 3.0% in the patients with acute bronchitis, respectively. The major anaerobes, isolated from TTA, were Peptostreptococcus micros and Prevotella melaninogenica. The aerobic bacteria were isolated with anaerobic bacteria in 32 of 42 patients at the same time. The quantitive grade of colonial growth of anaerobes was equal to or more than aerobes in the patients with lung abscess and pneumonia. We mostly administrated 3rd generation cephems or carbapenems with or without clindamycin for the treatment of anaerobic infections. Forty-one of 42 patients were cured only by the therapy of antimicrobial agents, but pneumonia patient with lung cancer died in spite of adequate antimicrobial therapy. These results suggest that the anaerobic infections are important in the bronchopulmonary infections.
Collapse
Affiliation(s)
- M Konishi
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Sakamoto M, Mikasa K, Hamada K, Konishi M, Maeda K, Yoshimoto E, Ueda K, Majima T, Sawaki M, Kita E, Narita N. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer]. Gan To Kagaku Ryoho 1998; 25:2259-66. [PMID: 9881083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
The treatment of a 14-membered ring macrolide, clarithromycin (CAM), prolongs the survival time of patients with unresectable nonsmall cell lung cancer, and improves the host factor. As we previously reported, one of the underlying mechanisms is that the treatment of CAM increases the bioactivity of interleukin-12 (IL-12). In the present study, we administered CAM to murine lung cancer treatment models with Lewis lung carcinoma and to 18 patients with unresectable non-small lung cancer whose anticancer treatment had been terminated. The timing of CAM administration was examined and the time course of NK activity was measured. In the murine lung cancer treatment models, administration of CAM 7 days after anticancer chemotherapy more strongly inhibited the tumor growth and more rapidly and significantly increased NK activity, compared to the concomitant use of CAM with an anticancer chemotherapy. In humans, the NK activity which had decreased after anticancer treatment, tended to be increased after one month of treatment with CAM (p = 0.06). One month of treatment with CAM significantly increased the NK activity (p < 0.05) of the following subjects: patients with stage III in the clinical stages, patients with squamous cell carcinoma, patients who had received radiotherapy alone as pretreatment therapy, and patients whose pretreatment therapy effect was partial response (PR). We conjectured that increasing NK activity was one of the underlying mechanisms of the macrobiotic effect of CAM. CAM was especially effective for patients in the early clinical stages and patients who responded well to pretreatment therapy. Murine lung cancer models showed that non-concomitant use of CAM with anticancer chemotherapy was more effective.
Collapse
Affiliation(s)
- M Sakamoto
- Second Dept. of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Ueda K, Konishi M, Maeda K, Hamada K, Sakamoto M, Yoshimoto E, Majima T, Mikasa K, Kita E, Sano R, Masutani T, Narita N. [Bacillus cereus septicemia in a patient with severe aplastic anemia]. Kansenshogaku Zasshi 1998; 72:1325-9. [PMID: 9916422 DOI: 10.11150/kansenshogakuzasshi1970.72.1325] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
A 78-year-old female was admitted with complaints of malaise and fatigue in the legs. The patient was diagnosed as severe aplastic anemia and treatment was started with metenolone and steroid pulse therapy. Administration of antibiotics and granulocyte-colony stimulating factor which led to a resolution of the high fever. About four months after admission, the patient developed vomiting and abdominal pain with a spiking fever. The next day after suddenly losing consciousness, she died. B. cereus was isolated from blood cultures. Autopsy specimens of the liver, cardiac muscle and lung showed changes due to B. cereus. This pathogen is widely distributed in nature. We should not overlook B. cereus as a contamination, but rather should consider it a potential pathogen in immunocompromised hosts, when it is isolated from blood cultures.
Collapse
Affiliation(s)
- K Ueda
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Konishi M, Yoshimoto E, Mikasa K, Narita N. [Systemic management of patients under anti-infection treatment]. Nihon Naika Gakkai Zasshi 1998; 87:2234-9. [PMID: 9921207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
|
27
|
Konishi M, Mori K, Yoshimoto E, Majima T, Ueda K, Teramoto S, Sakamoto M, Tsujimoto M, Maeda K, Mikasa K, Sawaki M, Narita N, Sano R, Masutani T. [Clinical evaluation of lung abscess diagnosed by transtracheal aspiration]. Kansenshogaku Zasshi 1998; 72:1193-6. [PMID: 9884505 DOI: 10.11150/kansenshogakuzasshi1970.72.1193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We have diagnosed lung abscess according to findings of infiltration with cavity formation on chest X-ray and/or CT-scan and pathogens isolated from transtracheal aspirates. We evaluated the clinical features of 20 patients with lung abscess (18 males and 2 females, mean age; 54.3 years). Diabetus mellitus and periodontal diseases were prominent underlying diseases in patients with lung abscess. Cough was complained in 13 patients, chest or back pain in 9, purulent sputum in 8 and hemosputum in 5 when the patients admitted to our hospital. A temperature higher than 38 degrees C was present in 12 patients but temperature les than 37 degrees C in 2. Multiple microorganisms were cultured from TTA in 15 patients. A mean of 2.7 bacterial species per patient was isolated, aerobes alone being isolated in 2 patients, anaerobes alone in 3, and mixed aerobic and anaerobic isolates in 10. Seventeen strains of aerobes and 35 of anaerobes were isolated. Major pathogens were Streptococcus pneumoniae, Streptococcus intermedius and other in aerobes, and Peptostreptococcus micros, Fusobacterium necrophorum, Prevotella melaninogenica and others in anaerobes. Abnormality of chest X-ray was located on the right upper lobe in 6 patients, the right lower lobe in 6, the left upper lobe in 6, the left lower lobe in 4 and the right middle lobe in 1. All patients were cured only by treatment of antimicrobial agents, but cavity formation on chest X-ray remained in 4 patients after the treatment.
Collapse
Affiliation(s)
- M Konishi
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Maeda K, Konishi M, Mikasa K, Majima T, Ueda K, Yoshimoto E, Sakamoto M, Hamada K, Sawaki M, Sano R, Masutani T, Narita N. [A clinical study of respiratory infection isolating non-pathogenic Neisseria by transtracheal aspiration]. Kansenshogaku Zasshi 1998; 72:1171-5. [PMID: 9884501 DOI: 10.11150/kansenshogakuzasshi1970.72.1171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Neisseria species other than N. meningitidis and N. gonorrhoeae are generally regarded as commensal bacterial flora of the oropharynx, and little is known regarding cases of these non-pathogenic Neisseria species in the lower respiratory tract. We clinically examined respiratory tract infections from which non-pathogenic Neisseria species were isolated by transtracheal aspiration (TTA). The incidence of non-pathogenic Neisseria isolated was 54 (15.7%) out of 344 episodes of respiratory tract infections with isolated microorganisms from TTA, and was 17.6%, 15.8%, 14.3% for pneumonia, acute bronchitis, and chronic lower respiratory tract infection, respectively. All 54 episodes were isolated with other microorganisms such as alpha-Streptococcus spp. (75.9%), Haemophilus influenzae (25.9%) and anaerobics (22.2%). The isolation ratio according to the age group increased at 45 years of age or more, but did not increase with the advance of age. Predisposing factors were identified such as overt aspiration, iatrogenic procedure and heavy smoking. Cases without overt aspiration that had fevers of 38 degrees C or more or hypoxemia of less than PaO2 70 torr when detecting non-pathogenic Neisseria were observed more frequently in the aged than the non-aged. The findings suggest the detection of non-pathogenic Neisseria by TTA is influenced by the host state that the fall of microorganisms from the upper to lower respiratory tract cannot be defended or excluded by mucociliary transportation disorder due to underlying disease and smoking, or deterioration of physical status other than overt or silent aspiration.
Collapse
Affiliation(s)
- K Maeda
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Kobayashi A, Mori K, Konishi M, Maeda K, Mikasa K, Yoneda T, Narita N, Sano R, Masutani T. [Two cases of Achromobacter xylosoxidans sepsis]. Kansenshogaku Zasshi 1998; 72:1070-5. [PMID: 9847526 DOI: 10.11150/kansenshogakuzasshi1970.72.1070] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Achromobacter xylosoxidans is a gram-negative bacterium whose natural habitat has not been clearly defined. It has been isolated from ear discharge and the large intestine of humans and from various hospital or environmental water sources. Infection with A. xylosoxidans in humans has been documented, and resulting illnesses include meningitis, pneumonia, cholecystitis, peritonitis and urinary tract infection. Bacteremia due to A. xylosoxidans is rare, and little information on treatment is available. Two cases of bacteremia due to A. xylosoxidans in patients with hemapoietic malignancies are reported herein. Case 1 involved a 70-yr. male whose clinical diagnosis was IgA lambda-type plasmacytoma. Case 2 involved 72-yr. male whose clinical diagnosis was acute lymphatic leukemia (L2). Both patients had been catheterized. Neutropenia was noted and the white blood cell counts were 20/microliter in case 1 and 35/microliter in case 2 when A. xylosoxidans was isolated from the blood culture. We suggest that bacteremia due to A. xylosoxidans may have been related to the presence of the catheter and neutropenia.
Collapse
Affiliation(s)
- A Kobayashi
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Mikasa K. Intraspecific variation in the effects of mating on emigration activity and fecundity in a natural population of Drosophila melanogaster. Genes Genet Syst 1998; 73:263-9. [PMID: 9880924 DOI: 10.1266/ggs.73.263] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Intraspecific variation in the effects of mating on the emigration response behavior and fecundity of Drosophila melanogaster was investigated using isofemale lines of the Himeji population in Japan. The emigration activities of the mated and unmated females were examined with Sakai's population system. The isofemale lines were classified into two groups with respect to the effect of mating on emigration activity; 1) copulation decreased the emigration activity in 26 out of 28 isofemale lines, and 2) higher emigration activity was noted in the mated than in the unmated females in two lines. The percentage of expressed genotypic variance on emigration activity was higher in the unmated females than in the mated ones. Gregarious oviposition did not seem to be related to the decrease of emigration activity in the mated females.
Collapse
Affiliation(s)
- K Mikasa
- Biological Laboratory, School of Dentistry, Meikai University, Saitama, Japan
| |
Collapse
|
31
|
Mikasa K, Sawaki M, Konishi M, Maeda K, Tsujimoto M, Mori K, Narita N, Koizumi A, Sano R, Masutani T. [An epidemiological investigation for MRSA and PRSP in Kinki area. Kinki Infection Working Group]. Kansenshogaku Zasshi 1998; 72:701-6. [PMID: 9745219 DOI: 10.11150/kansenshogakuzasshi1970.72.701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/11/2023]
Abstract
Recent trends in the development of resistance of the Staphylococcus aureus and Streptococcus pneumoniae to antibiotics were investigated, using a questionnaire delivered to participants at a meeting of the Kinki District Society of Infections. Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 55.4% of all isolated S. aureus, and more than 80% of MRSA was detected within hospitals. In outpatients, MRSA was often detected in pus, while in hospitalized patients, MRSA was often detected in sputum. Further, MRSA was accompanied by some other organisms (most frequently Pseudomonas aeruginosa) in 64.7% of MRSA positive patients. The sensitivity of MRSA to vancomycin (VCM) was 100%, to sulfamethoxazole-trimethoprim (ST) 99.2%, and to arbekacin, 98.6%. In contrast, Penicillin-resistant Streptococcus pneumoniae (PRSP) accounted for 42.4% of all isolates of Streptococcus pneumoniae. About 50% of PRSP was detected in out-patients. For both hospitalized patients and outpatients, PRSP was most frequently detected in sputum. PRSP was accompanied by some other organisms (most frequently Haemophilus influenzae) in 49.3% of PRSP positive patients, PRSP had high sensitivity to cephems, carbapenems and VCM.
Collapse
Affiliation(s)
- K Mikasa
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Konishi M, Mori K, Majima T, Ueda K, Teramoto S, Sakamoto M, Tsujimoto M, Maeda K, Mikasa K, Sawaki M, Koizumi A, Sano R, Masutani T, Narita N. [Clinical analysis of patients with sepsis--comparison between underlying diseases]. Kansenshogaku Zasshi 1998; 72:681-7. [PMID: 9745216 DOI: 10.11150/kansenshogakuzasshi1970.72.681] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We evaluated the clinical data in 83 patients with sepsis, which was diagnosed by both Bone's definition of sepsis and positive isolates from blood culture, according to their underlying diseases. This study enrolled a total of 117 septic episodes in 83 patients (57 males and 26 females, mean age: 52.0 years). We classified 3 groups, including hematological malignancies (46 patients, 72 episodes), solid malignant tumors (23 patients, 25 episodes) and non-malignancies (14 patients, 20 episodes), by the underlying diseases. Of the total number of isolates from blood culture, 53.0% were single gram-positive bacteria, 33.3% were single gram-negative bacteria, 7.7% were single fungus and 6.0% were polymicrobial organisms. In addition, coagulase negative staphylococci was isolated most often in patients with hematological malignancies. Sepsis was often caused by infectious focuses of hemorrhoid, stomatitis or intravenous catheter in patients with hematological malignancies, by pneumonia in patients with solid malignant tumors and by urinary tract infection in patients with non-malignancies. Mortality of sepsis in patients with solid malignant tumors (48%) was highest in 3 groups. Septic patients, who were complicated with shock and/or DIC, has poor prognosis in all groups. Serum albumin level was significantly lower in dead patients than patients who survived. These results suggest that clinical features may be different according to the underlying diseases of patients with sepsis.
Collapse
Affiliation(s)
- M Konishi
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Tomoda K, Hamada K, Fukuoka K, Tsukaguchi K, Tsujimoto M, Mikasa K, Choh S, Yoneda T, Narita N. [Small cell lung cancer associated with nephrotic syndrome: remission after chemotherapy]. Nihon Kokyuki Gakkai Zasshi 1998; 36:541-4. [PMID: 9754006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
A 66 year-old man was found to have pointed out a 1-cm tumor shadow, on a chest X-ray film when he underwent a gastrectomy because of advanced gastric cancer. Five months after the operation, edema and proteinuria developed, and a chest X-ray film revealed enlargement of the tumor. There was no sign of recurrence of the gastric cancer. Nephrotic syndrome due to IgA-nephropathy and small cell lung cancer was diagnosed. Chemotherapy (carboplatin and etoposide) was effective against both the lung tumor and the nephrotic syndrome. Small cell lung cancer may have been involved in the pathogenesis of the nephrotic syndrome in this patient.
Collapse
Affiliation(s)
- K Tomoda
- Department of Respiratory Medicine, Saiseikai Suita Hospital, Osaka
| | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Teramoto S, Kita E, Mikasa K, Hamada K, Konishi M, Maeda K, Sakamoto M, Tsujimoto M, Mori K, Sawaki M, Narita N. [Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer]. Jpn J Antibiot 1998; 51 Suppl A:53-5. [PMID: 9597486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
35
|
Ueta K, Hamada K, Mikasa K, Teramoto M, Sakamoto S, Konishi M, Maeda K, Tsujimoto M, Mori K, Majima T, Sawaki M, Kita E, Narita N. [Evaluation of BRM (biological response modifier) action of clarithromycin (CAM)--effect on cytokine expression in a mouse lung cancer model]. Jpn J Antibiot 1998; 51 Suppl A:57-60. [PMID: 9597487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
36
|
Sakamoto M, Mikasa K, Sawaki M, Hamada K, Teramoto S, Ueta K, Majima T, Konishi M, Maeda K, Tsujimoto M, Mori K, Kita E, Narita N. [Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer]. Jpn J Antibiot 1998; 51 Suppl A:50-2. [PMID: 9597485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
37
|
Konishi M, Mori K, Teramoto S, Sakamoto M, Tsujimoto M, Maeda K, Hamada K, Mikasa K, Sawaki M, Koizumi A, Sano R, Masutani T, Narita N. [Campylobacter jejuni enteritis in three patients with HIV infection]. Kansenshogaku Zasshi 1997; 71:1071-4. [PMID: 9394561 DOI: 10.11150/kansenshogakuzasshi1970.71.1071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Gatrointestinal symptoms, which include diarrhea, are as common as respiratory symptoms in patients with HIV infection. Gastrointestinal symptoms may result from infections, neoplasma, HIV enteropathy or drug toxicity. Three HIV-infected patients admitted to our hospital complaining of diarrhea and fever. We confirmed their diagnosis as Campylobacter jejuni enteritis by bacteriological examination of their feces. All of them had eaten inadequately cooked meat in restaurants before the onset of their enteritis. Their symptoms immediately improved after the administration of antimicrobial agents. One strain of C. jejuni isolated in our cases, however, was resistant to ofloxacin. This case report suggests that we must counsel HIV-infected patients to avoid inadequately cooked food and observe resistant patterns of C. jejuni to antimicrobial agents in Japan in the future.
Collapse
Affiliation(s)
- M Konishi
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Maeda K, Sawaki M, Mikasa K, Konishi M, Sakamoto M, Tsujimoto M, Hamada K, Kita E, Narita N. [Effect of cessation of erythromycin therapy on diffuse panbronchiolitis]. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35:948-53. [PMID: 9396251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The effect of cessation of erythromycin (EM) therapy against diffuse panbronchiolitis was studied. Nine cases were examined. After cessation of EM therapy, the manifestations of disease were stable in five cases, but worsened in the other four. In the former five, the period from the onset of disease until EM therapy began was relatively short; when EM therapy was stopped the manifestations of disease had almost completely disappeared and chest roentgenography revealed resolution of diffuse, small, nodular opacities without remarkable bronchiectasis. In contrast, in the latter four cases, the clinical manifestations of disease did not disappear, and chest-roentgenographic evidence of bronchiectasis was common before the cessation of EM therapy. In conclusion, EM therapy for diffuse panbronchiolitis may be stopped if the clinical manifestations of disease (especially purulent sputum) disappear, if diffuse, nodular opacities resolve almost completely and if there is no evidence of bronchiectasis.
Collapse
Affiliation(s)
- K Maeda
- Second Department of Internal Medicine, Nara Medical University, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Teramoto S, Konishi M, Mikasa K, Hamada K, Maeda K, Sakamoto M, Tsujimoto M, Mori K, Ueda K, Sano R, Masutani T, Sawaki M, Narita N. [A case of multiple muscular abscesses of the lower limbs by Staphylococcus aureus after chemotherapy for lung cancer]. Kansenshogaku Zasshi 1997; 71:939-43. [PMID: 9339633 DOI: 10.11150/kansenshogakuzasshi1970.71.939] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
A 67-year-old male was admitted to our hospital because of lung cancer and interstitial pneumonia. Cisplatin, vindesie and mitomycin C were administered for treatment of lung cancer. The leucocyte-counts declined to 1700/microliter on the eighth day after the chemotherapy. Though granulocyte colony-stimulating factor was administered, pain in the right thigh and high grade fever developed. Because Staphylococcus aureus was isolated from the blood specimen, piperacillin was administered. But the high grade fever continued and the pain was expanded to the right hip, left hip, thigh and leg. Because a computed tomograph of the lower limbs showed low density areas in bilateral gluteus maximus muscle right adductor magnus muscle, left biceps femoris muscle and left soleus muscle and the culture of an aspirate from abscess of right leg detected S. aureus, multiple muscular abscesses of the lower limbs was confirmed. We changed the antibiotics from PIPC to imipenem/cilastatin and minocycline on nineteenth day after the chemotherapy. His symptoms improved after the change of antibacterial agents. But he died of acute exacerbation of interstitial pneumonia, after about two months of the chemotherapy. Muscular abscesses of the limbs are very rare in Japan. Only four cases with muscular abscess of the limbs were reported in Japan, since 1988. This case suggests that a muscular abscess must be considered in the differential diagnosis of fever in patients with neutropenia.
Collapse
Affiliation(s)
- S Teramoto
- Internal Medicine II, Nara Medical University, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Sawacki M, Sakamoto M, Mikasa K, Kita E, Teramoto S, Hamada K, Konishi M, Maeda K, Tsujimoto M, Hirai T, Mori K, Ueda K, Narita N. 275 Anti-cachectic effect of clarithromycin in inoperable non-small cell lung cancer patients. Lung Cancer 1997. [DOI: 10.1016/s0169-5002(97)89658-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
41
|
Mikasa K, Sawaki M, Kita E, Hamada K, Sakamoto M, Konishi M, Maeda K, Teramoto S, Tsujimoto M, Mori K, Ueda K, Narita N. 276 Significant survival benefit of clarithromycin treatment for patients with unresectable lung cancer. Lung Cancer 1997. [DOI: 10.1016/s0169-5002(97)89657-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
42
|
Mikasa K, Sawaki M, Kita E, Hamada K, Teramoto S, Sakamoto M, Maeda K, Konishi M, Narita N. Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin. Chemotherapy 1997; 43:288-96. [PMID: 9209786 DOI: 10.1159/000239580] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
We carried out a randomized study of 49 consecutive patients with unresectable primary lung cancer to determine whether clarithromycin (CAM), a 14-membered ring macrolide, can improve outcome. A total of 49 patients (42 patients with non-small-cell lung cancer and 7 patients with small-cell lung cancer) had received prior chemotherapy, radiotherapy or both during their hospital stay. They were randomly allocated into two study groups on the first visit after discharge: 25 patients (22 patients with non-small-cell lung cancer, 3 patients with small-cell lung cancer) were assigned to receive CAM (400 mg/day, orally), and 24 patients (20 patients with non-small-cell lung cancer, 4 patients with small-cell lung cancer) did not receive CAM. CAM treatment after randomization was open and the treatment was to be continued as long as the patients could tolerate CAM. There was no significant difference in the median survival time for small-cell lung cancer between the CAM group and the non-CAM group. However, CAM treatment significantly increased the median survival time for non-small-cell lung cancer patients, the median survival for the CAM group was 535 days and that for the non-CAM group was 277 days. Analyses of prognostic factors showed that only treatment with CAM was predictive of longer survival for non-small-cell lung cancer, and other tested covariates had no effects on the prognosis. There were no remarkable side effects observed in the CAM group throughout treatment. We conclude that long-term treatment using CAM is beneficial for unresectable non-small-cell lung cancer patients and that it can increase the median survival of patients with advanced disease.
Collapse
Affiliation(s)
- K Mikasa
- Department of Medicine II, Nara Medical University, Kashihara, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Mori K, Konishi M, Sawaki M, Ueda K, Teramoto S, Sakamoto M, Tsujimoto M, Maeda K, Hamada K, Mikasa K, Narita N, Sano R, Masutani T, Kita E. [Prognostic analysis of sepsis in patients with lung cancer]. Kansenshogaku Zasshi 1997; 71:501-6. [PMID: 9248265 DOI: 10.11150/kansenshogakuzasshi1970.71.501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Sepsis is one of the most serious infections occurring in patients with lung cancer. Thus, we determined what is most predisposing factor in prognosis of sepsis in lung cancer patients; the type of causative bacteria, neutropenia or host nutritional status. A total of 27 lung cancer patients with sepsis, which consisted of 23 males and 4 females (mean age 70.7 +/- 6.6), were included in this study. The study was conducted from 1991 to 1995. All subjects were classified into the survival group and the dead group. Staphylococcus aureus or Esherichia coli most frequently isolated from the blood of the patients in the survival group, while either E. coli alone or multiple organisms were predominant in the dead group. Neutropenia did not affect the outcome of sepsis in lung cancer patients. In contrast nutritional status, as determined by serum albumin levels, was closely related to the mortality in septic lung cancer patients. These results predict that the prognosis of sepsis is dependent on nutritional status of lung cancer patients.
Collapse
Affiliation(s)
- K Mori
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Tsujimoto M, Sawaki M, Sakamoto M, Mikasa K, Hamada K, Maeda K, Teramoto S, Mori K, Ueda K, Narita N, Kita E. [The evaluation of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) level in peripheral blood of patients with chronic lower respiratory tract infection]. Kansenshogaku Zasshi 1997; 71:430-6. [PMID: 9209124 DOI: 10.11150/kansenshogakuzasshi1970.71.430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
In the present study, we assessed the serum level of IL-6 and TNF-alpha by ELISA in patients with chronic lower respiratory tract infection. The serum levels of IL-6 and TNF-alpha of patients in acute exacerbation phase are higher than that of in stable phase. We also classified patients in acute exacerbation phase into two groups according to the microorganism of persistent infection. The serum level of IL-6 and TNF-alpha in the patients with persistent infection with Pseudomonas aeruginosa were higher than that with Haemophilus influenzae. Moreover, the serum level of IL-6 and TNF-alpha were found to be related with malnutrition which assessed by clinical indices such as the serum level of albumin and cholinesterase. The present result suggests that IL-6 and TNF-alpha may have relationship with not only inflammation in airway but also indices of nutrition in patients with chronic lower respiratory tract infection.
Collapse
Affiliation(s)
- M Tsujimoto
- Second Department of Internal Medicine, Nara Medical University
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Teramoto S, Kita E, Mikasa K, Hamada K, Konishi M, Maeda K, Sakamoto M, Tsujimoto M, Mori K, Sawaki M, Narita N. [Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration]. Jpn J Antibiot 1997; 50 Suppl A:42-4. [PMID: 9597438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
46
|
Mikasa K, Sawaki M, Kita E, Hamada K, Sakamoto M, Konishi M, Maeda K, Teramoto S, Tsujimoto M, Mori K, Ueda K, Fukuoka K, Segawa K, Kataoka T, Narita N. [Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer]. Jpn J Antibiot 1997; 50 Suppl A:45-8. [PMID: 9597439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
47
|
Sakamoto M, Mikasa K, Hamada K, Teramoto S, Konishi M, Maeda K, Tsujimoto M, Mori K, Sawaki M, Kita E, Narita N. [Efficacy of clarithromycin on cancer cachexia in patients with primary non-small cell lung cancer]. Jpn J Antibiot 1997; 50 Suppl A:38-41. [PMID: 9597437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
48
|
Konishi M, Sawaki M, Mori K, Mikasa K, Maeda K, Imae T, Yamanaka K, Ueta K, Teramoto M, Sakamoto M, Tsujimoto M, Hamada K, Narita N, Kita E, Yoshioka A. [Log-term administration of clarithromycin as a possible adjuvant therapy of HIV infections]. Jpn J Antibiot 1997; 50 Suppl A:137-9. [PMID: 9597467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
49
|
Hamada K, Sakamoto M, Mikasa K, Teramoto M, Mori K, Tsujimoto M, Maeda K, Konishi M, Sawaki M, Narita N, Kita E. [Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells]. Jpn J Antibiot 1997; 50 Suppl A:28-31. [PMID: 9597434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
50
|
Mikasa K, Sawaki M, Kita E, Hamada K, Sakamoto M, Teramoto S, Narita N. [Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer]. Nihon Naika Gakkai Zasshi 1997; 86:100-7. [PMID: 9102408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
|